Breaking News

BioStem Begins Construction of New Lab

Will support production and development of pharmaceutical and cell based products

BioStem Technologies, Inc. began construction of its new pharmaceutical grade lab facility. The new facility will house multiple general labs, clean rooms, and small batch manufacturing rooms to support production and development of pharmaceutical, nutraceutical and cell based products.
 
“This facility will give our scientists and researchers the laboratory resources they need to rapidly develop new products. We’re looking forward to streamlining our development and manufacturing processes, and having the ability to test efficacy of these compounds in-house,” said Andrew Van Vurst, chief operating officer of BioStem Technologies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters